Back to calendar
BioMarin Pharmaceutical Inc. (BMRN) Earnings
BMRN reports earnings on Tuesday, August 4, 2026
earnings report
August 4, 2026 · Before Market Open
Q2 2026
Est. EPS: $0.95
Actual EPS: $0.76
EPS surprise: 9.81%
Company overview
Market Cap$11.6B
PriceUSD 60.00
P/E43.78
EPS (TTM)1.37
52-week high66.28
52-week low49.26
SectorHealth Technology
IndustryBiotechnology
Employees3,221